Pallavi Kishor Vawhal

Dr. Pallavi Kishor Vawhal

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
PVPallavi Kishor Vawhal
Pallavi Kishor Vawhal
SJShailaja Bhanudas Jadhav
Shailaja Bhanudas Jadhav
SKSumit Kaushik
Sumit Kaushik
KPKAHNU CHARAN PANIGRAHI
KAHNU CHARAN PANIGRAHI
CNChandan Nayak
Chandan Nayak
IIIbrahim Abdel Aziz Ibrahim
Ibrahim Abdel Aziz Ibrahim
Recent research on dipeptidyl peptidase-IV (DPP-IV) inhibitors has made it feasible to treat type 2 diabetes mellitus (T2DM) with minimal side effects. Therefore, in the present investigation, we aimed to discover and develop some coumarin-based sulphonamides as potential DPP-IV inhibitors in light of the fact that molecular hybridization of many bioactive pharmacophores frequently results in synergistic activity. Each of the proposed derivatives was subjected to an in silico virtual screening, and those that met all of the criteria and had a higher binding affinity with the DPP-IV enzyme were then subjected to wet lab synthesis, followed by an in vitro biological evaluation. The results of the pre-ADME and pre-tox predictions indicated that compounds 6e, 6f, 6h, and 6m to 6q were inferior and violated the most drug-like criteria. It was observed that 6a, 6b, 6c, 6d, 6i, 6j, 6r, 6s, and 6t displayed less binding free energy (PDB ID: 5Y7H) than the reference inhibitor and demonstrated drug-likeness properties, hence being selected for wet lab synthesis and the structures being confirmed by spectral analysis. In the in vitro enzyme assay, the standard drug Sitagliptin had an IC50 of 0.018 µM in the experiment which is the most potent. All the tested compounds also displayed significant inhibition of the DPP-IV enzyme, but 6i and 6j demonstrated 10.98 and 10.14 µM IC50 values, respectively, i.e., the most potent among the synthesized compounds. Based on our findings, we concluded that coumarin-based sulphonamide derivatives have significant DPP-IV binding ability and exhibit optimal enzyme inhibition in an in vitro enzyme assay.

29 March 2022 in International journal of health sciences
Verified
Journal Article
Open access
PDF file
PVPallavi Kishor Vawhal
Pallavi Kishor Vawhal
SJShailaja B. Jadhav
Shailaja B. Jadhav
In present work, we aimed at preparing coumarin and sulfonamide containing moieties into a single candidate template i.e. 3-chloro-2-oxo-N-(arylcarbamoyl)-2H-1-benzopyran-6-sulfonamides for the purpose of synergistic activity as potent DPP-IV inhibitors. The designed derivatives were subjected for the calculations of Lipinski rule, Veber’s rule, ADME analysis, drug-likeness properties and molecular docking. The derivatives which successfully passed all the criteria were proceeded for wet lab synthesis and biological evaluation. From the initial screening through Lipinski rule, Veber’s rule, ADME calculations, and drug-likeness properties, molecules 1a, 1f, 1g, 1h, 1i, 1j, 1k, 1o, 1p, 1q, 1r, 1v, 1w, and 1x successfully passed all the filters and displayed most drug-likeness nature. Therefore only these molecules were subjected for molecular docking studies. From molecular docking results, we have selected 1f, 1g, 1i, 1j, and 1v for the wet lab synthesis and biological evaluation. The structures of all the synthesized compounds were confirmed by spectral analysis and were subjected for in vitro DPP-IV enzyme assay. Sitagliptin was used as standard for the assay and it displayed 0.018 µM IC50 value. Compound 1f, 1g, 1i, 1j, and 1v exhibited 15.55, 15.85, 13.95, 14.48, and 13.45 µM IC50 values respectively.

15 November 2021 in Journal of Pharmaceutical Research International
Verified
Journal Article
Closed access
PDF file
PVPallavi Kishor Vawhal
Pallavi Kishor Vawhal
SJShailaja B. Jadhav
Shailaja B. Jadhav
Aim: In the present work, we have designed and synthesized indole-fused coumarin derivatives as potential antibacterial and antifungal agents. Place and Duration of Study: The present work was carried out at PEA's Modern college of Pharmacy, Sector 21, Yamunanagar, Nigdi- 411044 between the duration of January-2021 to May-2021. Methodology: The in vitro antibacterial and antifungal activity was performed by disc diffusion method. The antibacterial activities were tested using agar nutrient medium against Bacillus subtilis, Bacillus pumilus, Escherichia coli, and Pseudomonas aeruginosa that are representative types of gram-positive and gram-negative organisms respectively. The anti-fungal activity of all the compounds were determined on potato dextrose agar medium against Aspergillus niger and Candida albicans. Clotrimazole 100 μg/ml was used as a standard and DMF was used as control. Results: It was observed that all the compounds were sensitive to the gram +ve bacteria. Compound 2c, 2e, and 2f were sensitive to gram –ve bacteria. Compounds 2a, 2b, and 2f were sensitive to both the fungal strains while all the derivatives were sensitive to Candida albicans. Conclusion: From present investigation it has been observed that compound 2f was sensitive against gram +ve, gram –ve, and both the strains of fungal strains. Structurally, compound 2f possess aldehyde functional group at indole nucleus. Therefore, from present study we have concluded that compound 2f is a lead molecule for the further development of potential antibacterial and antifungal agents.